Recent research has not been able to demonstrate close endometrial morphological correlations with specific abnormalities of menstrual bleeding, but has pointed to an increasing number of molecular mechanisms that may be involved in the occurrence of certain forms of abnormal uterine bleeding. Ovulatory and anovulatory dysfunctional uterine bleeding (DUB) and progestogen-related breakthrough bleeding (BTB) are three conditions with quite different clinical characteristics. It is also probable that the local endometrial molecular mechanisms associated with these three menstrual disturbances are quite different Ovulatory DUB is associated with a series of vascular and haemostatic disturbances that all appear to contribute to increased loss of blood and tissue fluid at menstruation. Anovulatory DUB is associated with obvious disturbances of endometrial histology, vascular morphology and fragility, with variable and increased blood flow. Progestogen-related BTB is associated with a multitude of morphological and functional endometrial changes that appear to relate predominantly to a patchy capillary origin for the bleeding. Many molecular and cellular changes have been observed in all three conditions. It is not yet known whether there is a single, but different, underlying mechanism responsible for these multiple abnormalities in each of the three clinical situations.
Introduction
Disturbances of menstrual bleeding are a major medical and social problem for women, their families and the health services. In fact, disturbances of bleeding are relatively common in all age groups between 10 and 55 years. Menstrual disorders are the second most common gynaecological condition resulting in hospital referral (Coulter et al, 1989) , and affect up to one-third of women of child-bearing age (Hallberg et al, 1966; Gath et al., 1987) . One of the commonest of these conditions is dysfunctional uterine bleeding. For those women using hormonal contraceptive methods, minor disturbances of menstrual bleeding (breakthrough bleeding; BTB) are a common occurrence, and represent the most frequent reason stated for discontinuation of progestogenonly contraceptive methods (Belsey et al, 1988) . Irregular bleeding with hormonal contraception tends to be light in volume, but may be frequent or prolonged. Women may interpret prolonged bleeding as heavy (Fraser, 1983a) , and be concerned for the long-term health effects of extended bleeding episodes. Because these contraceptive methods are safe, effective, flexible and economical, and there are no established methods of regulating the bleeding without the addition of oestrogens, disturbances of the menstrual bleeding pattern represent a considerable management problem.
The term dysfunctional uterine bleeding (DUB) refers to excessively heavy, prolonged or frequent bleeding (most commonly heavy, i.e. menorrhagia) which is not caused by pregnancy or any recognizable pelvic or systemic disease (Fraser, 1989) . DUB is a diagnosis of exclusion, and will apply LS.Frastr, M.Hickey and J.-ySong in 40-60% of cases of excessive menstrual bleeding (Cameron, 1989; Fraser, 1989) . Ovarian cycles associated with excessive bleeding may be ovulatory or anovulatory. In modern Western society, DUB is ovulatory in ~80% of cases (Cameron, 1989) . Bleeding in these circumstances tends to be heavy and/or prolonged, but is generally regular. Anovulatory DUB is seen most commonly at the beginning and end of reproductive life, and may be irregular and/or excessive (Schroder, 1954) . It needs to be recognized that there are widespread differences in the definition of 'dysfunctional uterine bleeding', especially in the USA where ovulatory DUB is not widely acknowledged as a specific condition (Allen-Davis and Schlaff, 1995; Fraser, 1996) .
Regardless of its perceived cause, menstrual bleeding that fails to occur at regular or predictable times, or bleeding that is of markedly reduced or excessive quantity, is poorly accepted by the majority of women (Snowden and Christian, 1983) . The implication of this is that many women will be more favourably disposed to a contraceptive method if it causes regular periods with normal flow than if there is some departure from the norm. This study was carried out >15 years ago (Snowden and Christian, 1983) , and in many Western societies nowadays it appears that young women will often be happy to accept amenorrhoea, provided that the method has a high contraceptive efficacy and that the amenorrhoea is not likely to signify a risk of pregnancy. Women are also sensitive to more subtle characteristics of menstrual bleeding, such as the colour, composition and odour of the loss. For many women, disruptions in menstrual bleeding have perceived implications for health and fertility. However, it is not widely recognized that spontaneous disturbances of menstrual patterns are quite common at all ages. Many women accept and tolerate these well, provided that serious pathology has been excluded and that disturbances are of limited duration.
Ovulatory dysfunctional uterine bleeding

Clinical characteristics and endocrinology
This condition is characterized by excessive menstrual bleeding (usually very heavy), usually at fairly regular intervals and with a pattern of daily menstrual loss similar to normal menses, with 90% of the flow occurring during the first 3 days (Haynes et al., 1979) . The onset of bleeding coincides with oestradiol and progesterone withdrawal during luteolysis, and the circulating pituitary and gonadal hormone patterns during the preceding 4 weeks are indistinguishable from normal (Haynes et al., 1979; Eldred and Thomas, 1994) .
Endometrial morphology and tissue breakdown
Normal menstruation involves the breakdown, remodelling and repair of the functional endometrial layers, and there is some evidence that disruptions of this process at a number of stages may result in changes in the quantity and pattern of menstrual loss. Endometrial destruction and regeneration are largely controlled by local factors, although the initial trigger comes from falling oestradiol and progesterone concentrations following luteolysis. Lysosomes release hydrolytic enzymes in pre-menstrual endometrium that appear to contribute to tissue breakdown, bleeding, remodelling and subsequent regeneration (Henzl et al., 1972; Christiaens etal, 1982) . These organelles are sensitive to falling concentrations of progesterone, and it is unclear whether they have a primary or secondary role in the onset of endometrial menstrual breakdown. Endometrial lysosomal enzyme activity in women with ovulatory DUB is increased, and this activity is also observed in women with menorrhagia secondary to intrauterine device (IUD) use (Wang, 1994) . Matrix metalloproteinases (MMP) also act to degrade most components of the extracellular matrix and are regulated by ovarian steroid hormones (Rodgers et al., 1994) . Excessive or prolonged tissue degradation due to MMP activity could result in increased or prolonged menstrual bleeding. Certain MMP are strongly expressed in menstrual endometrium (Salamonsen, 1996) . There is also recent evidence consistent with the hypothesis that decreasing concentrations of progesterone result in a fall in the endometrial tissue concentrations of neutral endopeptidase (a glycosylated zinc metallopeptidase capable of inactivating a number of endocrine and paracrine peptides) and a consequent rise in tissue concentra- tions of locally synthesized endothelins which may be responsible for the vasoconstriction leading to the onset of tissue breakdown. This release of endothelins may be attenuated in ovulatory DUB (Marsh, 1996) .
Endometrial leukocytes are known to be involved in tissue destruction and regeneration. In the normal menstrual cycle there is a substantial pre-menstrual increase in endometrial stromal granulated lymphocytes, T lymphocytes and macrophages. Polymorphonuclear leukocytes only appear in uterine tissues at the onset of menstruation (Kamat and Issacson, 1987; Buhner et aL, 1988) , and are often located near blood vessels in the endometrium, where they may influence vascular permeability and integrity. Polymorphs also appear in focal endometrial necrosis associated with high-dose progestogens (Song et aL, 1996) . This influx of leukocytes into human endometrium is clearly influenced by changes in circulating (or tissue) steroid concentrations, especially progesterone and progestogens, and small populations of these cells have varying oestradiol and/or progesterone receptor positivity (Tabibzadeh and Satyaswaroop, 1989) .
Granulated stromal lymphocytes, macrophages and other migratory leukocytes may be implicated in the control of menstrual blood loss (MBL) and contribute to mechanisms of excessive loss. An excessive leukocyte infiltrate has been associated with the copper IUD (Sheppard, 1987) . Macrophages may release platelet-activating factor (PAF) and prostaglandin (PG) E, both of which are potent vasodilators that could augment MBL. Mast cells may also secrete a range of vasoactive substances.
Endometrial vascular morphology, function and haemostasis
There is a large body of evidence to implicate a number of endometrial vascular and haemostatic abnormalities in the bleeding disturbances occurring with ovulatory DUB. The observations of Markee (1940) suggest that normal menstrual bleeding arises predominantly from the spiral arterioles, and is under the control of ovarian steroid hormones. The pattern of excessive menstrual bleeding in ovulatory DUB suggests that the bleeding site may also be arteriolar, but with a change in the local control of endometrial blood flow and haemostatic mechanisms. There is little evidence that spiral arteriole morphology or density (Rees et aL, 1984) are altered in ovulatory DUB, but there may be an increase in the numbers of small veins in the deep endometrium and inner myometrium (Houlihan et aL, 1989) . Ovarian steroid hormones are known to have vasoactive effects, and the vessels of the functional layer of the endometrium show marked sensitivity to their influence (Fraser and Peek, 1992) . Oestrogen causes a fall in uterine vascular resistance and an increase in endometrial blood flow (Fraser et aL, 1987) . This effect is lost with the appearance of progesterone. The influence of oestrogen and progesterone on the endometrial vasculature appears to be by direct receptor-mediated effects on the arteriolar and venular musculature or by local mediators because receptors have not been demonstrated on the endothelial cells in the functional layer (Perrot-Applanat et aL, 1988) . The actions of ovarian steroid hormones may be potentiated in DUB by the release of various local mediators through an increase in endometrial oestrogen (ER) and progesterone receptors (PR) in glandular and stromal tissue (Gleeson et aL, 1993) , but endometrial oestrogen and progesterone receptor expression is indistinguishable from normal in women with menorrhagia (Critchley et aL, 1994) .
In women with ovulatory DUB there is a significant increase in endometrial blood flow compared with normal, and this is seen during the period of raised oestradiol secretion in the foUicular phase (Fraser etal., 1987) . There is a subsequent decrease in flow in the secretory phase, with a late premenstrual rise equivalent to that seen in normal cycles. It is unclear whether the increased endometrial flow in the follicular phase has any direct influence on MBL. Blood flow within the endometrium during days 1 and 2 of menstruation is probably under the control of complex local mechanisms, but these may be influenced by vascular changes earlier in the cycle.
The control of menstrual bleeding relies to a considerable extent on the timely and adequate constriction of bleeding vessels. PG and endothelins appear to be powerful vasoactive substances in the control of MBL, and their production is (Cameron et al, 1987; Smith and Kelly, 1987) . Ovulatory DUB is associated with a shift in the ratio of endometrial vasoconstricting PGFza to vasodilatory PGEj (Smith et al, 1982) and an increase in the total endometrial concentration of PG (Cameron et al, 1987) . Smith et al. (1981) have also shown that there is an increased capacity for myometrial generation of prostacyclin (PGI2) from endometrial precursors in ovulatory DUB. PGI 2 is a vasodilatory PG and is a potent inhibitor of platelet aggregation. Endometrial tissues may also be more responsive to the action of other vasodilatory PG (PGEJ via increased receptor concentrations in women with menorrhagia (Adelentado et al, 1988) . Successful treatment of ovulatory DUB with PG synthetase inhibitors leads to a reduction in endometrial concentrations of PGF^ and PGE2 (Fraser, 1983b) , and inhibits the binding of PGE to its receptor (Rees et al, 1988) .
Endothelins, located predominantly at the endometrial-myometrial junction (Cameron et al, 1992) , act as powerful vasoconstrictors and are responsive to ovarian steroid concentrations (Maggi et al, 1991) . Tissue endothelin concentrations may interact with relaxing factors such as endothelium-derived relaxing factor (EDRF), also known as nitric oxide (NO; Goetz et al, 1988) . Disrupted patterns of endothelin production may prolong or increase MBL, either directly or via NO production, and recent evidence suggests that endothelin concentrations in the endometrium of women with ovulatory DUB may be depressed substantially (Marsh, 1996) .
Active fibrinolysis within the normal endometrium and uterine cavity prevents organized clot formation and the development of intrauterine adhesions. The 'defective' haemostasis seen in normal menstruation may be exaggerated in ovulatory DUB. Vascular plugs are loose and located inside vessels, and reduced fibrin concentrations make them unstable (Sheppard, 1990) . Ovulatory DUB is associated with an increase in endometrial fibrinolysis (Rybo, 1966) , and an increased concentration of tissue plasminogen activator (tPA) has been observed in these women (Kasonde and Bonnar, 1976) . Overacu'vation of these fibrinolytic mechanisms may 'unbalance' the haemostatic system, causing early breakdown of thrombi in the endometrial vessels and excessive blood loss. Excessive oestrogen stimulates fibrinolysis, and progesterone inhibits this process by creating a decidual reaction with an increased concentration of endogenous fibrinolytic inhibitors (Cassldn and Astedt, 1983) . Mast cells may also play a role in the defective haemostatic process. They have been shown to degranulate pre-menstrually to secrete heparin, histamine and other substances (Salamonsen, 1996) . Heparin stimulates endometrial fibrinolysis via the secretion of tPA, and histamine causes endothelial cell contraction, creating gaps between vascular endothelial cells to allow increased vascular fluid loss. In DUB, the secretion of heparin-like substances is increased (Foley et al, 1978) . There are also probably local effects on platelet function, preventing their efficient aggregation, and the most likely candidate for this role is the excessive generation of myometrial prostacyclin, demonstrated in ovulatory DUB by Smith et al. (1981) .
Endometrial repair
For menstrual bleeding to cease, there must be repair of the epithelium and vascular endothelium initiated from the remaining basal layers of endometrium. Local factors are likely to play a central role in this reparative process. This aspect of endometrial function may be disrupted in those women with ovulatory DUB associated with prolongation of bleeding, although it is probably intact in the majority who present with mehorrhagia (and normal patterns of menstrual loss). There is evidence that endometrial repair processes are considerably delayed following curettage, which suggests that under normal circumstances cells or cellular products from residual areas of the functional layer are important in normal endometrial remodelling and repair (Johannisson et al., 1981) . This makes it likely that regrowth from the basal layer alone is much less efficient, and excessive shedding could have an impact on the rate of regeneration.
During normal menstruation the superficial endometrial layers are lost and major endometrial remodelling occurs. Regeneration begins within 24 h and is complete within 4-5 days of the Fraser, 1990) . Key: MMP -matrix metalloproteinases; NEPneutral endopeptidase; PLA 2 -phospholipase A 2 ; PGFj, -prostaglandin F2,; PGE2 -prostaglandin E 2 ; eGLendometrial granulated lymphocytes; PMNLpolymorphonuclear leucocytes; EDRF -endothelium-derived relaxing factor (nitric oxide); E2 -oestradiol; b-FGF -basic fibroblast growth factor, VEGF -vascular eodotheUal growth factor. onset of menstruation (Ferenczy, 1976a,b) . Growth factors in the endometrium may be crucial to the speed and efficacy of the reparative process. The secretion of potent endometrial growth factors, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF), is influenced by circulating ovarian steroid hormones (Smith, 1990) , although it is unclear how important any direct effect of oestradiol may be on epithelial proliferation and repair in this situation. In DUB, delayed or incomplete endometrial repair could prolong menstrual bleeding episodes, but nothing is known about such mechanisms. Cyclical angiogenesis in the functional layer could be disrupted in DUB, such that new vessels fail to respond to the normal control mechanisms of vasoconstriction and regeneration. This may be more important in anovulatory DUB. It is not known whether there are any subtle disturbances of endometrial angiogenesis in ovulatory DUB, although major disturbances could not be demonstrated (Peek et al, 1995a) .
Anovulatory dysfunctional uterine bleeding
Clinical characteristics and endocrinology This condition tends to be characterized by unpredictable, irregular, prolonged and/or excessively heavy episodes of bleeding. It is much more common at the extremes of reproductive life and is the only type of DUB widely acknowledged in the USA (Allen-Davis and Schlaff, 1995). Many peri-menopausal women will experience anovulatory cycles interspersed with ovulatory or defective ovulatory cycles, which makes their menstrual experience quite unpredictable (Fraser, 1996) . The type of bleeding that occurs after a particular anovulatory cycle will depend on the endometrial effect of the peak, duration and rate of decline of serum oestradiol concentrations, and excessive bleeding is often associated with simple hyperplastic changes in the endometrium. Bleeding may be light and intermittent, with lowish oestradiol concentrations and proliferative endometrium, and withdrawal bleeding may even not occur at all if oestrogen withdrawal is gradual (Corner, 1942) . Bleeding can occur at any time endocrinologically speaking (when oestradiol concentrations are falling, stable or even rising) from endometrium exposed to increased and unopposed oestradiol concentrations (Brown et al, 1959; Fraser, 1976) . In women with anovulatory DUB, the types of oestrogen secreted by the ovaries are normal and their metabolism is also normal, but the pattern of secretion is greatly disturbed (Fraser and Baird, 1974) . Inappropriately high and fluctuating concentrations of oestradiol and oestrone are secreted by multifollicular ovaries (Schroder, 1954; Fraser and Baird, 1974) , suggesting a primary disturbance of intra-ovarian folh'cular control mechanisms or a marked disturbance of hypothalamic-pituitary gonadotrophin control.
Endometnal morphology and breakdown
Major changes are seen in endometrial morphology in women with simple hyperplasia as a consequence of excessive and unopposed ovarian oestradiol secretion (Schroder, 1954) . This clinical picture can be so dramatic that it was known previously as 'metropathia haemorrhagica', although it is now recognized as merely one end of the spectrum of severity of anovulatory DUB. In these women, the endometrium appears to break down erratically and unevenly in different parts of the cavity. SchrSder (1954) found scattered 'red patches corresponding to thrombotic foci of necrotic disintegration' throughout the abnormally proliferated tissue, even in women who were not bleeding at the time of examination. These necrotic patches were detected in up to 87% of endometrial specimens from women with hyperplasia. The borders of the necrotic tissue were usually sharply defined from intact proliferative tissue, but there were few histological signs of any tissue interaction at the interface.
Endometrial vascular morphology, function and
haemostasis Hysteroscopic studies frequently demonstrate the presence of large, thin-walled tortuous and fragile superficial endometrial vessels in women with hyperplasia or carcinoma, and these vessels may be much larger than those commonly seen in progestogen-only users.-. These abnormal vessels are probably a key part of the aetiology of very heavy bleeding in these women, although one also has to postulate a mechanism leading to trauma, other types of damage or excessive fragility of the vascular endothelium and overlying epithelium in order for bleeding to begin. In hyperplastic endometrium, the growth of spiral arterioles is suppressed and the density of venous drainage within the inner myometrium is greatly increased (Beilby et al., 1971) . These may both be morphological changes which interfere with normal vascular control mechanisms.
Little is known about disturbances in the local endometrial environment that may lead to irregular menstrual bleeding in anovulatory DUB. Endometrial blood flow rates are variable but tend to be higher than normal (Fraser et al., 1987) . This may reflect the oestrogen dominance in anovulatory cycles. In persistently proliferative endometrium, arachidonic acid availability is reduced and overall PG production is impaired (Smith et al, 1982) . An imbalance in PG activity may alter vascular tone, endometrial blood flow and haemostatic function. Without coordinated vasoconstriction and dilatation, patterns of menstrual bleeding are likely to be disrupted. As yet, there is no information on the possible role of endothelins in anovulatory DUB. Information on fibrinolytic activity is limited, but this activity may well be increased. There is recent evidence to suggest that endometrial nitric oxide (the endothelium-derived relaxing factor) release may be stimulated by oestrogen, and this could be part of the mechanism of increased bleeding with anovulatory DUB.
Endometrial repair
Virtually nothing is known specifically about the endometrial events during recovery from an episode of anovulatory bleeding. It is assumed that increased oestradiol concentrations will have a substantial impact on the rate of surface repair and may sometimes lead to the development of hyperplastic endometrium within a few days of an episode of bleeding. The involvement of other growth factors is unknown.
Progestogen-related BTB mechanisms
Three previous symposia have been organized in the last 17 years by the Special Programme of Research, Development and Research Training of the World Health Organization (the third being organized jointly with the National Institutes of Health, Washington, DC, USA) to address the issue of abnormal bleeding associated with the use of long-acting hormonal contraceptives d'Arcangues et al, 1990; Alexander and d'Arcangues, 1992) . A study of these three publications demonstrates the extent of the progress that has been made during this time in understanding the mechanisms of normal and abnormal menstruation. It also demonstrates the relative lack of progress that has been possible in the actual prevention and treatment of these bleeding disturbances. Nevertheless, the amount of progress made Clinical characteristics and endocrinology BTB is generally worst during the first few months after starting progestogen-only contraceptive use, and bleeding patterns then improve in the long term. With methods like depot medroxyprogesterone acetate, amenorrhoea and oligomenorrhoea are then common, while Norplant® users tend to develop more regular patterns with average flow. Users of the intrauterine levonorgestrel-releasing system (Levonova®, Mirena®; Leiras, Finland) tend to develop extremely light but regular bleeds. The initial erratic episodes of bleeding common with these methods are related to changes which occur in the endometrium, and do not generally correlate with fluctuations in serum concentrations of endogenous or exogenous steroids. Increasing evidence suggests that a continuing low level oestrogen influence and a continuous progestogen exposure on the endometrium are necessary to allow erratic BTB to begin and be maintained (Table I) . Other factors then come into play.
Increasing evidence suggests that a certain limited amount of oestrogen effect within the endometrium, in addition to continuous progestogen exposure, is necessary for BTB to occur. In conditions close to complete histological atrophy, amenorrhoea is the rule and BTB does not occur. As the continuous progestogen effect becomes increasingly established with continued exposure, BTB generally becomes less and less. Those Norplant users with BTB tend to have higher circulating concentrations of oestradiol than those without. On the other hand, higher relative concentrations of oestrogen will 'stabilize' the endometrium and minimize the incidence of BTB, as seen in combined oral contraceptive pill users. Even in pill users with a fixed oestrogen-progestogen ratio, there is a significant incidence of BTB with prolonged continuous use. It is likely that the local expression of oestrogen and progesterone receptors in different cell types within endometrium will turn out to be important in determining the conditions necessary for BTB to occur (Critchley et al, 1993; Lau and Rogers, 1996) .
Any factor that interferes with the relatively constant circulating concentrations of contraceptive steroids in users of long-acting methods, such as drug interactions with rifampicin or anticonvulsants, may cause BTB. Local damage to the endometrial surface with superficial endometritis (or to the cervix with cervicitis) may also lead to unpredictable spotting.
Endometrial morphology and breakdown
Numerous authors have described the histological changes that may occur in endometrium exposed to varying concentrations of continuous progestogen exposure, but the simple message is that no particular histological pattern appears to correlate with the occurrence of BTB (Ober, 1970; Johannisson, 1980; Maqueo, 1980) . Only the development of apparent extreme histological atrophy predicts a particular menstrual pattern -amenorrhoea. Endometrial breakdown during BTB is probably patchy, and bleeding is thought to occur from isolated areas rather than uniformly across the whole endometrial surface.
Endometrial vascular morphology, function and haemostasis In progestogen-exposed endometrium there is a reduction in spiral arteriole numbers and size with substantially reduced spiralling (Hourihan et al, 1986) . Microvascular density is increased by >50% (Rogers et al., 1993) , endothelial gaps appear (Hourihan et al., 1991) and there is an increase in the number of endothelial plasmalemmal vesicles and contracted endothelial cells (Johannisson et al, 1982) . Recently, hysteroscopic inspections have demonstrated scattered surface neovascularization in arborization patterns from a central stem in women with BTB during Norplant use (Hickey et al., 1996) . Thin-walled, enlarged and apparently dilated surface vessels sometimes appear (Ober, 1970; Maqueo, 1980; Hourihan et al, 1991; Song et al, 1995) . Their significance has been uncertain because they frequently do not contain red cells on histological examination, and it is difficult to assess vascular dilatation in vitro as the vessels rapidly collapse (Rogers et al, 1993) . However, recent in-vivo hysteroscopic examinations have demonstrated that these vessels (apparently thin-walled venules) are common on the surface of the endorrietrium of women with BTB using Norplant (Hickey et al, 1996) . Current evidence suggests that BTB originates from these fragile superficial venules and the scattered neovascular arborizations. Recent evidence, pointing to an increase in the expression of VEGF in Norplant-exposed endometrium, could be an explanation for the appearance of these abnormal vessels (Smith, 1996) .
There has been suspicion for some time of an increase in the fragility of endometrial vessels in long-acting progestogen users (Sarfati and Brux, 1973; Fraser and Diczfalusy, 1980 ), but it has been possible to confirm this only recently by direct hysteroscopic inspection of the endometrium (Hickey et al, 1996) . The mechanism of this markedly increased fragility is not known, but could be caused by subtle changes in basement membrane structure, intercellular tight junctions, intercellular adhesion molecules or integrity of the perivascular supporting structures. Endothelial gaps appear to be more common in progestogen users (Shaw et al, 1981) , suggesting that the loss of integrity of intercellular junctions may be the culprit.
The destructive processes that result in normal breakdown of the superficial endometrium at the onset of menstruation probably also play a part in the erratic breakdown associated with BTB. For abnormal bleeding to occur, there must be focal or generalized breakdown of both endothelial and epithelial layers, but it is not clear whether this occurs simultaneously in a coordinated fashion or if subepithelial bleeding leads to disruption of the overlying epithelial layers. It is probable that various different mechanisms are activated under different circumstances, and that matrix metalloproteinases (and their tissue inhibitors), lysosomes, free oxygen radicals, migratory white cells, cytokines and their regulatory systems may all be involved. Some MMP are intensely expressed in normal menstrual endometrium, but information on their role in BTB is lacking (Courtoy, 1996; Salamonsen, 1996) . Similarly, lysosomes play a role in normal menstruation, but their involvement in BTB is unclear. There is some evidence to confirm an increase in the endometrial release of enzymes, like N-acetyl-|J-hexosaminidase, on prolonged exposure to levonorgestrel (Comillie et al, 1991) . Free oxygen radical release has not been studied in progestogen-exposed endometrium.
The concentration of several types of migratory leukocyte increases in progestogen-exposed endometrium (Booker et al, 1994; Song et al, 1996) , with the potential for release of a range of destructive as well as angiogenic and repair molecules. These leukocytes consist mainly of T-lymphocytes, endometrial granulated lymphocytes and macrophages, although polymorphonuclear leukocyte concentrations also increase when tissue necrosis or breakdown occurs (Song et al., 1996) . There is no evidence of changes in mast cell function during progestogen-exposed cycles (Hourihan et al, 1991) , but more sensitive techniques may be necessary to confirm this. The actual role of each of these leukocyte types remains to be elucidated. (White et al, 1991; Marsh, 1996) . There appears to be a reduction in the endometrial secretion of cyclo-oxygenase enzyme products, which is more than offset by an increase in the release of cytochrome-P450 epoxygenase products (White et al, 1991) . Both epoxide and hydroxyeicosatetraenoic acid (HETES) release correlated with the number of bleeding days in long-term levonorgestrel users. An increase in prostaglandin epoxides may cause vasodilatation, and both epoxides and HETES may inhibit platelet aggregation while a decrease in endothelin expression may also lead to vasodilatation (Marsh, 1996) . As yet, there is no information on the possible role of nitric oxide or other vasoactive substances in BTB. Little information exists concerning possible changes in haemostatic mechanisms within the endometrium, although intravascular platelet and haemostatic plugs appear to be more common in progestogen users (Houlihan et al., 1986 ) and fibrinolytic activity is reduced. Immunostaining intensity for Von Willebrand Factor VHI-related antigen is increased in endometrial capillary endothelium of Norplant users, but the significance is unclear (Au and Rogers, 1993) . There is also recent evidence for an increase in endometrial stromal and periglandular expression of angiotensin, which may relate to changes in vascular function or growth (Li, 1996) .
Endometrial repair
The observation that episodes of progestogenrelated BTB may be prolonged and frequent suggests that endometrial repair mechanisms may be defective in this situation, although there is very little direct evidence to confirm this. Wonodirekso et al. (1993) have found the superficial endometrial epithelium to be absent in some of their Norplant users, with evidence of defective cytokeratin elements in the epithelial cytoskeleton of those women in whom epithelium is present. There is very little information available on the role of various growth factors in normal or abnormal endometrial repair in these women.
Angiogenesis is the process of growth of new blood vessels from existing vessels, and is an integral part of the cyclical repair and regeneration process of normal endometrium. Using the partially specific marker, proliferating cell nuclear antigen, Goodger et al. (1994) found evidence of reduced endothelial proliferation in women exposed to Norplant in whom endometrial microvascular density was already increased (Rogers et al, 1993) . The observation that growth of endometrial capillary endothelial cells exposed to certain synthetic progestogens in culture is markedly inhibited may also be an indicator of impaired angiogenic mechanisms (Peek et al., 1995b) . Evidence of increased VEGF in Norplant-exposed endometrium could be an explanation for the appearance of abnormal vascular morphology in these cases (Smith, 1996) . As yet, there is no information on the possible roles of different angiogenic, anti-angiogenic and other regulatory molecules that might be involved in these apparently defective repair processes.
A comparison of the features of ovulatory and anovulatory DUB and progestogen-related BTB
An attempt has been made in Table II hormones, but their action is almost certainly mediated via a range of local endometrial factors on the endometrial vasculature. The bleeding site in hormone-induced BTB may differ from that of normal menstrual bledding and excessive menstrual bleeding in both types of DUB. A capillary bleeding site for BTB may explain the observed characteristic pattern of prolonged and frequent light bleeding.
Endometrial capillaries or their supporting structures may be altered following exposure to exogenous steroid hormones, particularly long-acting progestogen-only preparations, and this may lead to increased vascular fragility. The endothelial basement membrane may be structurally or functionally disrupted by prolonged progestogen exposure, allowing changes in vascular morphology (such as dilatation) and leakage of erythrocytes, causing BTB. Intercellular integrity may be compromised by prolonged progestogen exposure, with the disruption of endothelial (and epithelial) cell tight junctions and diapedesis of erythrocytes. Epithelial integrity and mechanisms of repair may be altered following exposure to steroid contraceptives, such that blood loss from 'fragile' endometrial vessels escapes through the epithelium as BTB. These vessels may also be abnormal in size, structure and function. The addition of oestrogens after prolonged progestogen exposure may promote epithelial repair and limit endothelial bleeding.
Endometrial breakdown and repair are controlled by a wide variety of local substances, which are influenced by circulating concentrations of exogenous and endogenous steroid hormones. Disturbances in the concentrations and interactions of these factors are likely to be involved in changes in menstrual bleeding patterns. The roles of those factors affecting vascular integrity may be of particular importance in the genesis of BTB. A greater understanding of these mechanisms will undoubtedly lead to improved ideas for the prevention and management of the various bleeding disturbances. For example, it may be possible to design a small biodegradable uterine implant that could release continuous low concentrations of an appropriate substance to counteract a particular molecular disturbance. These could be designed for different dosages and durations of action, or even to release combinations.
